From: The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer
Durations of chemotherapy
n (%)
<6 M
147 (34.2 %)
6~12 M
94 (21.9 %)
12~24 M
139 (32.3 %)
>24 M
50 (11.6 %)